← Eichor
Study identifier: NCT06324201 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Condition: Paroxysmal Atrial Fibrillation  ·  Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

PhaseN/A
Planned participants250
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Observational, multi-center, non-randomized, post-market study. This is a nested sub-study of the REAL AF Registry. Consecutive symptomatic drug refractory paroxysmal atrial fibrillation (PAF) patients from the registry will be screened for enrollment, prospectively or retrospectively, to this sub-study per inclusion and exclusion criteria.

This description comes directly from the study's public registry record.

Talk to the study team

Jennifer Moss  ·  615-448-5770  ·  jmoss@hrcrs.com

Always discuss trial participation with your own doctor first.

Locations (21)

Arrhythmia Institute at GrandviewBirmingham, Alabama, United StatesRecruiting
Mobile Cardiology AssociatesMobile, Alabama, United StatesRecruiting
Community Memorial Health SystemVentura, California, United StatesRecruiting
Medical City - HCAAurora, Colorado, United StatesRecruiting
Naples Community HospitalNaples, Florida, United StatesWithdrawn
Sarasota Memorial HealthSarasota, Florida, United StatesRecruiting
Piedmont HealthcareAtlanta, Georgia, United StatesRecruiting
Norton Heart and Vascular InstituteLouisville, Kentucky, United StatesRecruiting
The Brigham and Womens HospitalBoston, Massachusetts, United StatesNot Yet Recruiting
Sparrow Clinical Research InstituteLansing, Michigan, United StatesRecruiting
Trinity Health-Michigan HeartYpsilanti, Michigan, United StatesRecruiting
The Christ HospitalCincinnati, Ohio, United StatesRecruiting

+ 9 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06324201